Nurix Therapeutics, Inc. (NRIX) Misses Q4 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: NRIX) | Delayed: 15.95 -9.87 (38.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.82 | 52 Week High | $ | |||
| Open | $17.16 | 52 Week Low | $ | |||
| Day High | $17.28 | P/E | N/A | |||
| Day Low | $14.78 | EPS | $ | |||
| Volume | 19,558,006 | |||||
